The facts are staggering. An estimated 1,000,000 Americans¹ are living with a brain tumor and approximately 94,390 more will be diagnosed in 2023. What’s more, pediatric brain tumors are the leading cause of cancer-related death among children and adolescents ages 0-19 years.1 Despite these statistics, brain tumor research remains underfunded. This is why Stryker’s Neurosurgical team is proud to partner with the National Brain Tumor Society for the third year in a row to help raise awareness and funds for brain tumor research.
"This month, we're proud to partner with the National Brain Tumor Society to support, empower, and amplify the voice of the brain tumor community as we work to advance neurosurgery and transform lives," said Jeff Gorton, Vice President and General Manager of Stryker's Neurosurgical business.
According to the National Brain Tumor Society, “the brain tumor experience is full of extraordinary challenges and extraordinary hope. The gray area that falls in between is what drives us, unrelentingly, toward our shared mission of conquering and curing brain tumors—once and for all.”² Use #GoGrayInMay or #GrayMay to show how you’re taking action and raising awareness to make lasting change for the brain tumor community.
Passionate employees take steps towards new brain cancer treatments
In 2019, Stryker released the Sonopet iQ Ultrasonic Aspirator, a technology that helps surgeons remove soft and fibrous brain tumor tissue and work near blood vessels and nerves. This product is helping to advance neurosurgical care.
Stryker employees are also passionate about raising awareness about this form of cancer by participating in a month-long move-a-thon. Employees, their family and friends are encouraged to log their steps to raise money for Brain Tumor Awareness Month. To raise awareness, employees are hosting a step challenge with a goal to reach 50 million steps. Additionally, Stryker’s Neurosurgical team is donating $25,000 to the National Brain Tumor Society.
“Brain cancer patients and their families exhibit strength and courage throughout their journey. It’s a privilege to support initiatives like this that are working to find a cure,” said Dylan Crotty, President of Stryker’s Instruments division.
David F. Arons, JD, Chief Executive Officer of the National Brain Tumor Society says, “Brain tumors are some of the toughest and most complex diseases on the planet. The generous support of sponsors like Stryker will improve the delivery of care in pursuit of better outcomes for patients.”
Employees have started their